Granulocyte colony-stimulating factor activating HIF-1alpha acts synergistically with erythropoietin to promote tissue plasticity.
Stroke and peripheral limb ischemia are serious clinical problems with poor prognosis and limited treatment. The cytokines erythropoietin (EPO) and granulocyte-colony stimulating factor (G-CSF) have been used to induce endogenous cell repair and angiogenesis. Here, we demonstrated that the combination therapy of EPO and G-CSF exerted synergistic effects on cell survival and functional recovery from cerebral and peripheral limbs ischemia. We observed that even under normoxic conditions, G-CSF activates hypoxia-inducible factor-1alpha (HIF-1alpha), which then binds to the EPO promoter and enhances EPO expression. Serum EPO level was significantly increased by G-CSF injection, with the exception of Tg-HIF-1alpha(+f/+f) mice. The neuroplastic mechanisms exerted by EPO combined with G-CSF included enhanced expression of the antiapoptotic protein of Bcl-2, augmented neurotrophic factors synthesis, and promoted neovascularization. Further, the combination therapy significantly increased homing and differentiation of bone marrow stem cells (BMSCs) and intrinsic neural progenitor cells (INPCs) into the ischemic area. In summary, EPO in combination with G-CSF synergistically enhanced angiogenesis and tissue plasticity in ischemic animal models, leading to greater functional recovery than either agent alone.
Liu
Shih-Ping
SP
Center for Neuropsychiatry, China Medical University Hospital, Taichung, Taiwan.
Lee
Shin-Da
SD
Lee
Hsu-Tung
HT
Liu
Demeral David
DD
Wang
Hsiao-Jung
HJ
Liu
Ren-Shyan
RS
Lin
Shinn-Zong
SZ
Su
Ching-Yuan
CY
Li
Hung
H
Shyu
Woei-Cherng
WC
D000818:Animals; D004357:Drug Synergism; D004359:Drug Therapy, Combination; D004921:Erythropoietin / Q000235:genetics / Q000627:therapeutic use*; D005786:Gene Expression Regulation / Q000187:drug effects*; D016179:Granulocyte Colony-Stimulating Factor / Q000627:therapeutic use*; D051795:Hypoxia-Inducible Factor 1, alpha Subunit / Q000378:metabolism* / Q000502:physiology; D007511:Ischemia / Q000188:drug therapy*; D051379:Mice; D018919:Neovascularization, Physiologic / Q000187:drug effects; D011401:Promoter Regions, Genetic; D013234:Stem Cells / Q000187:drug effects
D051795:Hypoxia-Inducible Factor 1, alpha Subunit; D004921:Erythropoietin; D016179:Granulocyte Colony-Stimulating Factor
Cancer Res. 2000 Aug 1;60(15):4010-5
10945599
Circ Res. 2001 Jul 6;89(1):47-54
11440977
J Clin Invest. 2005 Aug;115(8):2083-98
16007267
Stroke. 2002 May;33(5):1362-8
11988616
Nat Med. 2006 May;12(5):557-67
16648859
J Exp Med. 2003 Nov 3;198(9):1391-402
14597738
Br J Haematol. 2004 Jan;124(2):190-4
14687029
Brain Res. 2006 Feb 16;1073-1074:190-201
16423324
Stroke. 2004 Jul;35(7):1732-7
15178821
J Neurosci. 2005 Feb 16;25(7):1769-77
15716413
J Cereb Blood Flow Metab. 2006 Apr;26(4):556-64
16136056
Ann Hematol. 2006 Mar;85(3):174-80
16408206
Blood. 1994 Dec 15;84(12):4157-63
7527670
Cochrane Database Syst Rev. 2006 Jul 19;(3):CD005207
16856086
Diabetologia. 2006 May;49(5):1049-63
16506055
Brain Res. 2005 May 31;1045(1-2):22-30
15910759
J Biol Chem. 2000 Sep 1;275(35):26765-71
10837481
Psychoneuroendocrinology. 2006 Jan;31(1):38-48
15996825
Neuroreport. 2004 Jun 7;15(8):1225-9
15167538
Cardiovasc Res. 2007 Mar 1;73(4):823-32
17258698
J Neurosci. 2001 Jun 1;21(11):3895-903
11356877
Blood. 2004 Jul 15;104(2):321-7
15054036
J Clin Oncol. 1999 Apr;17(4):1288
10561191
J Biol Chem. 1996 Dec 13;271(50):32253-9
8943284
J Mol Cell Cardiol. 2007 Jun;42(6):1036-44
17498737
Blood. 2005 Jun 1;105(11):4258-63
15705785
Blood. 1998 May 1;91(9):3222-9
9558377
Brain Res. 2005 Apr 18;1041(2):125-31
15829221
J Neurochem. 2006 Jan;96(2):428-43
16336625
Brain Res. 2005 Oct 5;1058(1-2):120-8
16150422
J Mol Cell Cardiol. 2007 Mar;42(3):540-8
17223129
Blood. 1991 Oct 15;78(8):1954-62
1717076
Blood. 1999 Sep 1;94(5):1561-7
10477681
Circulation. 2004 Sep 28;110(13):1847-54
15381647
FASEB J. 2005 Dec;19(14):2005-7
16223785
J Cereb Blood Flow Metab. 2007 May;27(5):1043-54
17077815
J Clin Invest. 2008 Jan;118(1):133-48
18079966
Neurosci Lett. 2007 May 18;418(3):248-52
17449175
J Biol Chem. 2002 Nov 1;277(44):41750-5
12205091
J Interferon Cytokine Res. 2005 Nov;25(11):674-83
16318581
Drugs. 1994 Nov;48(5):731-60
7530630
Circ Res. 2005 Jun 10;96(11):1145-51
15879308
Circulation. 2004 Mar 30;109(12):1543-9
15023891
Nature. 1992 Oct 29;359(6398):843-5
1279431
Stroke. 2007 Sep;38(9):2584-91
17656664
J Pharmacol Exp Ther. 2006 Apr;317(1):109-16
16357210
Circulation. 2006 Feb 7;113(5):701-10
16461843
FASEB J. 2005 Feb;19(2):307-9
15574488
J Exp Biol. 2000 Apr;203(Pt 8):1253-63
10729275
J Neurosci. 2001 Dec 15;21(24):9733-43
11739582
Int J Biochem Cell Biol. 2005 Mar;37(3):535-40
15618010
Blood. 2007 Mar 15;109(6):2565-70
17110461